Works matching IS 17762596 AND DT 2021 AND VI 16 AND IP 2
Results: 11
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF Inhibitors.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 197, doi. 10.1007/s11523-021-00792-8
- By:
- Publication type:
- Article
Is Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Superior Even to Lenvatinib? A Matching-Adjusted Indirect Comparison.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 249, doi. 10.1007/s11523-021-00803-8
- By:
- Publication type:
- Article
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 215, doi. 10.1007/s11523-021-00798-2
- By:
- Publication type:
- Article
Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 165, doi. 10.1007/s11523-021-00794-6
- By:
- Publication type:
- Article
BRAFV600E Mutations Arising from a Left-Side Primary in Metastatic Colorectal Cancer: Are They a Distinct Subset?
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 227, doi. 10.1007/s11523-021-00793-7
- By:
- Publication type:
- Article
Utility of Cerebrospinal Fluid Cell-Free DNA in Patients with EGFR-Mutant Non-Small-Cell Lung Cancer with Leptomeningeal Metastasis.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 207, doi. 10.1007/s11523-021-00791-9
- By:
- Publication type:
- Article
Association Between Immune-Related Adverse Events and the Prognosis of Patients with Advanced Gastric Cancer Treated with Nivolumab.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 237, doi. 10.1007/s11523-021-00790-w
- By:
- Publication type:
- Article
A Randomized Phase I Study of Abemaciclib in Chinese Patients with Advanced and/or Metastatic Cancers.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 177, doi. 10.1007/s11523-020-00789-9
- By:
- Publication type:
- Article
Vaccine Therapies for Cancer: Then and Now.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 121, doi. 10.1007/s11523-020-00788-w
- By:
- Publication type:
- Article
The Evolving Landscape of Checkpoint Inhibitor Combination Therapy in the Treatment of Advanced Hepatocellular Carcinoma.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 153, doi. 10.1007/s11523-020-00787-x
- By:
- Publication type:
- Article
Impact of Dose-Effect in Smoking on the Effectiveness of Pembrolizumab in Patients with Metastatic Urothelial Carcinoma.
- Published in:
- Targeted Oncology, 2021, v. 16, n. 2, p. 189, doi. 10.1007/s11523-020-00786-y
- By:
- Publication type:
- Article